Baxalta Incorporated (NYSE: BXLT) and Precision BioSciences, the genome editing company, announced a global collaboration to develop a broad series ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE